問卷

TPIDB > Principal Investigator

Principal Investigator


Kuang Tien General Hospital (在職)

Division of Nephrology

Division of Endocrinology

更新時間:2023-09-19

王家良
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

11Cases

2019-02-15 - 2021-04-22

Phase III

Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
  • Condition/Disease

    Type 2 Diabetes Mellitus

  • Test Drug

    LY3298176

Participate Sites
9Sites

Terminated9Sites

1 2